Arkin Tech

Venture Capital Active Herzliya, Israel Est. 2009
Visit website ↗ LinkedIn
Last updated 2026-06-18
Portfolio
10
in our dataset
Rounds participated
12
Rounds led
2
Rounds' value
$106.5M
total disclosed, rounds participated
Stages
B Round, A Round, F Round, Seed, C Round, D Round, E Round, G Round, Pre-Seed

About

Arkin Capital is a multi-stage investment firm managing over $2 billion. Initially focused on health and life sciences, particularly biotech, it has expanded into technology, sustainability, private equity, and real estate. The firm invests across early-stage to pre-IPO opportunities, leveraging expertise in each sector. Its portfolio includes a range of funds and sectors, with a consistent approach to backing ventures in areas with proven growth potential.

Arkin Tech makes direct investments in tech companies.

Portfolio · 10

Harmoniz
Development of GH Seeds
1 round Latest: 2024-12
Honeycomb Insurance
Real Estate Insurance Technology
1 round $36.0M committed Latest: 2024-05
Plantopia
Plant-Based Molecular Farming Platform Producing High-Quality Micellar Casein
1 round $6.0M committed Latest: 2023-01
Virility Medical
Skin Patch for the Treatment of Premature Ejaculation
Led ★ 3 rounds $19.2M committed Latest: 2022-07
Pixellot
AI-automated Sports Production
1 round $16.0M committed Latest: 2020-06
OdysightAI
Visual Sensing and Video-Based Predictive Maintenance Systems
Led ★ 1 round $2.0M committed Latest: 2020-05
SoniVie
Pulmonary Hypertension Denervation Treatment
1 round $9.8M committed Latest: 2018-01
Quiet Therapeutics
Anticancer Therapeutics Using Nanoparticles and Biomarkers
1 round $5.5M committed Latest: 2013-01
cCAM Biotherapeutics
Monoclonal Antibodies for Cancer Treatment
1 round $8.0M committed Latest: 2012-09
Metallo-Therapy
Gold Nanoparticles for Cancer Management
1 round $4.0M committed Latest: 2011-05

Investment activity

3 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences5
Agriculture & Food Technologies2
Media & Entertainment Technologies1
Undisclosed1
Fintech & Insurtech1
Industrial Technologies1

Funds · 3

  • Arkin Bio Capital — $270M Jan 2021
  • Arkin Bio Ventures 2 — $140M Mar 2020
  • Arkin Bio Ventures 1 — $60M Jun 2016

Q&A

What is Arkin Tech's primary investment focus?
Arkin Tech, part of Arkin Capital, initially focused on health and life sciences, particularly biotech. It has since expanded into technology, sustainability, private equity, and real estate, making direct investments in tech companies.
What is the most recent fund raised by Arkin Tech?
Arkin Tech raised Arkin Bio Capital in January 2021, though the specific amount for this fund is private.
Can you name a recent exit for Arkin Tech?
SoniVie was acquired by Boston Scientific for $400M in March 2025, representing a notable exit for Arkin Tech.
Which sectors does Arkin Tech primarily invest in?
According to startupim data, Arkin Tech has a strong concentration in Health Tech & Life Sciences, followed by Agriculture & Food Technologies.
What are some of Arkin Tech's notable portfolio companies?
Arkin Tech's portfolio includes companies like Honeycomb Insurance, which raised a $54.7M Series B, and Pixellot, which secured a $234M Series D round.
Who are the key individuals leading Arkin Tech?
Mori Arkin is the Founder & Chairman, and Nir Arkin serves as the CEO of Arkin Tech.
What is the typical investment stage for Arkin Tech?
Arkin Tech invests across multiple stages, including Seed, A Round, B Round, C Round, D Round, E Round, F Round, G Round, and Pre-Seed.
When was Arkin Tech founded?
Arkin Tech was founded in 2009.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)